Lv6
3088 积分 2022-09-22 加入
Chimeric antigen receptor T cell therapy for autoimmune disease
3个月前
已完结
Advancements and challenges in CAR T cell therapy in autoimmune diseases
3个月前
已完结
A Novel Anti-CD38 Monoclonal Antibody for Treating Immune Thrombocytopenia
4个月前
已完结
Dose intra‐subject escalation to an event (DIETE): A new method for phase 1 dose‐finding utilizing systematic intra‐subject dose escalation with application to T‐cell engagers
5个月前
已完结
T-cell-engaging bispecific antibodies in cancer
5个月前
已完结
Phase 1 Study of Safety and Preliminary Clinical Activity of JNJ-63898081, a PSMA and CD3 Bispecific Antibody, for Metastatic Castration-Resistant Prostate Cancer
5个月前
已完结
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
5个月前
已完结
Identification of novel prognostic autoantibodies in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone via a high-throughput antigen microarray
6个月前
已完结
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
11个月前
已完结
T-cell-engaging bispecific antibodies in cancer
11个月前
已完结
皖公网安备34019202002308
